Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Marius Wunderle"'
Autor:
Annika Behrens, Peter A. Fasching, Eva Schwenke, Paul Gass, Lothar Häberle, Felix Heindl, Katharina Heusinger, Laura Lotz, Hannah Lubrich, Caroline Preuß, Michael O. Schneider, Rüdiger Schulz-Wendtland, Florian M. Stumpfe, Michael Uder, Marius Wunderle, Anna L. Zahn, Carolin C. Hack, Matthias W. Beckmann, Julius Emons
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-11 (2023)
Abstract Background High mammographic density (MD) is a risk factor for the development of breast cancer (BC). Changes in MD are influenced by multiple factors such as age, BMI, number of full-term pregnancies and lactating periods. To learn more abo
Externí odkaz:
https://doaj.org/article/cb11d28d4c694224bb3f06b545fc309f
Autor:
Tara Zuhair Kassem, Marius Wunderle, Lukas Kuhlmann, Matthias Ruebner, Hanna Huebner, Juliane Hoyer, André Reis, Peter A. Fasching, Matthias W. Beckmann, Carolin C. Hack, Rainer Fietkau, Luitpold Distel
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 8, Pp 6618-6633 (2023)
Background: Individual radiosensitivity is an important factor in the occurrence of undesirable consequences of radiotherapy. The potential for increased radiosensitivity has been linked to highly penetrant heterozygous mutations in DNA repair genes
Externí odkaz:
https://doaj.org/article/9aebbc8e3c064932ba9791c9a8ea5e53
Autor:
Georgia Vasileiou, Maria J. Costa, Christopher Long, Iris R. Wetzler, Juliane Hoyer, Cornelia Kraus, Bernt Popp, Julius Emons, Marius Wunderle, Evelyn Wenkel, Michael Uder, Matthias W. Beckmann, Sebastian M. Jud, Peter A. Fasching, Alexander Cavallaro, André Reis, Matthias Hammon
Publikováno v:
BMC Medical Imaging, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background BRCA1/2 deleterious variants account for most of the hereditary breast and ovarian cancer cases. Prediction models and guidelines for the assessment of genetic risk rely heavily on criteria with high variability such as family can
Externí odkaz:
https://doaj.org/article/5e14d0b00d1249af9a862faab333192c
Autor:
Ramona Erber, Miriam Angeloni, Robert Stöhr, Michael P. Lux, Daniel Ulbrich-Gebauer, Enrico Pelz, Agnes Bankfalvi, Kurt W. Schmid, Robert F. H. Walter, Martina Vetter, Christoph Thomssen, Doris Mayr, Frederick Klauschen, Peter Sinn, Karl Sotlar, Katharina Stering, Albrecht Stenzinger, Marius Wunderle, Peter A. Fasching, Matthias W. Beckmann, Oliver Hoffmann, Rainer Kimmig, Nadia Harbeck, Rachel Wuerstlein, Fulvia Ferrazzi, Arndt Hartmann
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 15, p 8716 (2022)
In intermediate risk hormone receptor (HR) positive, HER2 negative breast cancer (BC), the decision regarding adjuvant chemotherapy might be facilitated by multigene expression tests. In all, 142 intermediate risk BCs were investigated using the PAM5
Externí odkaz:
https://doaj.org/article/aed511032752487bac880db052f7203c
Autor:
Michael G. Schrauder, Lisa Brunel-Geuder, Lothar Häberle, Marius Wunderle, Juliane Hoyer, Roland Csorba, André Reis, Rüdiger Schulz-Wendtland, Matthias W. Beckmann, Michael P. Lux
Publikováno v:
European Journal of Medical Research, Vol 24, Iss 1, Pp 1-9 (2019)
Abstract Background Growing demand for risk-reducing surgery in individuals with inherited susceptibility to cancer leads to the question whether these procedures are cost effective for the executing hospitals. This study compared the clinical costs
Externí odkaz:
https://doaj.org/article/7f5571eccc094b409264f0fa8ab90a5b
Autor:
Julius Emons, Peter A. Fasching, Marius Wunderle, Felix Heindl, Jens Rieger, Florian Horn, Georg Pelzer, Andre Ritter, Thomas Weber, Marcus Radicke, Iris Polifka, David L. Wachter, Evelyn Wenkel, Thilo Michel, Michael Uder, Arndt Hartmann, Gisela Anton, Matthias W. Beckmann, Rüdiger Schulz-Wendtland, Sebastian M. Jud
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Mammography can identify calcifications up to 50–100 μm in size as a surrogate parameter for breast cancer or ductal carcinoma in situ (DCIS). Microcalcifications measuring
Externí odkaz:
https://doaj.org/article/ae489d9be52b4f80970e6d8ca4d29e99
Autor:
Paul Gass, Michael P. Lux, Claudia Rauh, Alexander Hein, Mayada R. Bani, Cornelia Fiessler, Arndt Hartmann, Lothar Häberle, Jutta Pretscher, Ramona Erber, David L. Wachter, Rüdiger Schulz-Wendtland, Matthias W. Beckmann, Peter A. Fasching, Marius Wunderle
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates predictors of the res
Externí odkaz:
https://doaj.org/article/27207d1303ab4a1fa4d061a8ebdcbf30
Autor:
Juliane Hoyer, Georgia Vasileiou, Steffen Uebe, Marius Wunderle, Cornelia Kraus, Peter A. Fasching, Christian T. Thiel, Arndt Hartmann, Matthias W. Beckmann, Michael P. Lux, André Reis
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Breast cancer is the most common cancer in women. 12–15% of all tumors are triple-negative breast cancers (TNBC). So far, TNBC has been mainly associated with mutations in BRCA1. The presence of other predisposing genes seems li
Externí odkaz:
https://doaj.org/article/8e037917e9c44ddd89800f578b54ab09
Autor:
Caroline Preuss, Marius Wunderle, Carolin C. Hack, Matthias W. Beckmann, Evelyn Wenkel, Sebastian Jud, Felix Heindl
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 148:301-306
Was ist neu? Risikofaktoren Hormonelles Ungleichgewicht, Gynäkomastie, Lifestyle-Faktoren und genetische Veränderungen (insbesondere BRCA2-Mutationen) zählen zu den Hauptrisikofaktoren für das Mammakarzinom beim Mann. Prognose Die Brustkrebserkra
Autor:
Fabienne Lange, Marius Wunderle, Katharina Grasruck, Caroline Preuß, Matthias W. Beckmann, Carolin C. Hack, Sebastian M. Jud, Arndt Hartmann, Peter A. Fasching, Rüdiger Schulz-Wendtland, Ramona Erber
Publikováno v:
Frauenheilkunde up2date. 15:415-432